Cargando…
First brazilian consensus of advanced prostate cancer: recommendations for clinical practice
INTRODUCTION: Prostate cancer still represents a major cause of morbidity, and still about 20% of men with the disease are diagnosed or will progress to the advanced stage without the possibility of curative treatment. Despite the recent advances in scientific and technological knowledge and the ava...
Autores principales: | Sasse, Andre Deeke, Wiermann, Evanius Garcia, Herchenhorn, Daniel, Bastos, Diogo Assed, Schutz, Fabio A., Maluf, Fernando Cotait, Coura, George, Morbeck, Igor Alexandre Protzner, Cerci, Juliano J., Smaletz, Oren, Lima, Volney Soares, Adamy, Ari, de Campos, Franz Santos, Carvalhal, Gustavo Franco, Cezar, Leandro Casemiro, Dall´Oglio, Marcos Francisco, Sadi, Marcus Vinicius, dos Reis, Rodolfo Borges, Nogueira, Lucas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462130/ https://www.ncbi.nlm.nih.gov/pubmed/28199075 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0490 |
Ejemplares similares
-
Second brazilian consensus on the treatment of advanced prostate cancer: a SBOC-SBU-SBRT panel review
por: Sasse, Andre Deeke, et al.
Publicado: (2019) -
Castration-resistant prostate cancer: systemic therapy in 2012
por: Maluf, Fernando C., et al.
Publicado: (2012) -
Renal cell cancer treatment: an expert panel recommendation from the
Latin American cooperative group-genitourinary and the Latin American renal
cancer group: focus on surgery
por: de Cássio Zequi, Stênio, et al.
Publicado: (2019) -
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)
por: Soares, Andrey, et al.
Publicado: (2020) -
The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels
por: Werutsky, Gustavo, et al.
Publicado: (2019)